According to Interface News, Zhu Tong, the chief operating officer of Qiansheng Zaiming and senior vice president of Xiansheng Pharmaceutical, joined Zaiding Pharmaceutical as the chief commercial officer of Greater China today. Liang Yi, the company's current chief commercial officer and president of Greater China, will leave Zaiding Pharmaceutical on April 30. On the same day, Zaiding Pharmaceutical confirmed the above information, but did not further explain the personnel changes in this position in the company.
再鼎医药首席商务官梁怡将离职，曾一手搭建商业化团队
Liang Yi, the chief commercial officer of Zaiding Pharmaceutical, will leave her job and once set up a commercialization team
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.